Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Safer Aging With Diabetes Monitoring

Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Who May Be Eligible (Plain English)

Who May Qualify: - Age 75 years and older - Diagnosis of Type 2 Diabetes - Current treatment with insulin - Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization) - Able to communicate in English - Able to access email and the Internet Who Should NOT Join This Trial: - On renal dialysis - Dementia - Pacemaker or Automatic Implantable Cardioverter Defibrillator - Using insulin pump - Severe Mental Illness - Severe Visual Impairment - In Hospice - Current or recent CGM use Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age 75 years and older * Diagnosis of Type 2 Diabetes * Current treatment with insulin * Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization) * Able to communicate in English * Able to access email and the Internet Exclusion Criteria: * On renal dialysis * Dementia * Pacemaker or Automatic Implantable Cardioverter Defibrillator * Using insulin pump * Severe Mental Illness * Severe Visual Impairment * In Hospice * Current or recent CGM use

Treatments Being Tested

BEHAVIORAL

SAGE Group Sessions

Participants enroll in 3 educational group sessions and receive CGMs

OTHER

Usual Care

Participants continue to receive usual care (Control Arm)

Locations (4)

Kaiser Permanente Fremont
Fremont, California, United States
Kaiser Permanente San Jose
San Jose, California, United States
Kaiser Permanente San Leandro
San Leandro, California, United States
Kaiser Permanente - Union City
Union City, California, United States